NHAS
PTCT icon

Novo Holdings A/S’s PTC Therapeutics PTCT Stock Holding History

Novo Holdings A/S’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-597,359
Closed -$12.8M – 9
2013
Q4 		$12.8M Sell
597,359
-150,000
-20% -$2.64M 1.88% 6
2013
Q3 		$11.2M Buy
+747,359
New +$13M 2.78% 4

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Novo Holdings A/S's PTCT Position: Q1 2014 in Review

Novo Holdings A/S sold out of PTC Therapeutics (PTCT) in Q1 2014, closing a stake of 597,359 shares — an estimated $12.8M sold.

Novo Holdings A/S first reported a position in PTCT in Q3 2013 and held it in 2 quarters. The position peaked at $12.8M in Q4 2013. 65 funds tracked by Wall St. Rank hold PTCT as of Q1 2014.

  • Novo Holdings A/S reported no remaining PTC Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Novo Holdings A/S sold 597,359 PTC Therapeutics shares in Q1 2014, an estimated $12.8M.
  • Novo Holdings A/S first reported a position in PTC Therapeutics in Q3 2013 and held it in 2 quarters.
  • Novo Holdings A/S's PTC Therapeutics position peaked at $12.8M in Q4 2013.
  • 65 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2014.

Based on Novo Holdings A/S's 13F filing for Q1 2014, filed 14 Aug 2014.